Denise de Wijs on Thursday announced that she has been promoted to Finance Director at Teva Pharmaceuticals’ Malta operations, and will start working in her new position in April.
Prior to this, she served as Director of Accounting at the company’s operations in Benelux for almost four years. She was also Associate Director of Accounting and Financial Reporting at Teva Pharmaceuticals for 10 months.
For more than 15 years, Ms De Wijs worked as Audit Senior Manager at professional services firm PwC’s office in the Netherlands, during which time she managed the audits of statutory accounts, numerous special projects such as acquisitions, public debt and listing transactions, and was also Group Audit Senior Manager of large multinational companies. While working at PwC, she also served as Audit Manager at its Canada office, and also as Group Reporting Specialist at energy and petrochemical company Shell.
She conducted a postgraduate study to become a registered accountant from Vrije Universiteit Amsterdam and higher education in accountancy from The Hague University of Applied Sciences.
Founded in 1901, Teva Pharmaceuticals is a medicine developer and producer, that has a portfolio of 3,500 products. It has a presence in multiple countries, including a production site in Żejtun, Malta. The Malta site’s roots trace back to 1976, and became part of Teva Pharmaceuticals in 2016.
Featured Image:
Teva Malta's Żejtun site / Teva Malta / Facebook
Jonathan Shaw and David Borg – the CEO and Head of People, Talent & Development for Retail Marketing Ltd share ...
Konnekt COO Lara Camilleri takes part in a feature that first appeared on Business Now magazine delving into the impacts ...
Having been sick three times in the past two months, he had to rely on the company’s team to step ...
During 2022, the amount of clean energy generated by the airport increased by 53.2% from the previous year to a ...